{"meta":{"query_hash":"53a01e2d7de3","filters":{"venue":"Canadian oncology today."},"cohort_total":23,"direct_labels_cover":0,"predictions_cover":23,"exported":23,"export_cap":100000,"truncated":false,"label_status":"direct model label, unvalidated","prediction_status":"machine_predicted_unvalidated (Codex and Gemma teacher distillation)","score_status":"score_only:v0-immature-baseline","snapshot":{"source":"OpenAlex, pinned release, all 482 partitions","release":"2026-06-24","frame_built":"2026-07-12"},"permalink":"https://metacan.xera.ac/q/53a01e2d7de3","api":"https://metacan.xera.ac/api/v1/cohort?venue=Canadian+oncology+today."},"results":[{"id":"W4403604639","doi":"10.58931/cot.2024.1223","title":"Survivorship Issues in Testicular Cancer","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"University of British Columbia","funders":"Canadian Institutes of Health Research; National Institutes of Health; Prostate Cancer Foundation; U.S. Department of Defense","keywords":"Survivorship curve; Testicular cancer; Cancer survivorship; Cancer; Medicine; Gerontology; Psychology; Internal medicine","score_opus":0.024069372259093218,"score_gpt":0.361931690930239,"score_spread":0.3378623186711458,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403604639","genre_codex":"commentary","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.07217944,0.17184338,0.0016103021,0.6446445,0.0073087914,0.000121584846,0.00076708564,0.00010275759,0.10142222],"genre_scores_gemma":[0.69760466,0.18129334,0.0016768427,0.08222215,0.018108875,0.00015492435,0.0010549825,0.000068459136,0.017815841],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99791604,0.0009667595,0.00013805176,0.0001029277,0.0005455572,0.0003306716],"domain_scores_gemma":[0.9908455,0.00326598,0.0010176655,0.00022460561,0.0018605177,0.0027857814],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002601226,0.00012555606,0.00034417052,0.0009944944,0.003395578,0.0017333819,0.0007059688,0.0013295467,0.009471865],"category_scores_gemma":[0.014335373,0.00010033574,0.00035508402,0.0013617326,0.0016696174,0.0021286933,0.0021350433,0.0026666247,0.0006051738],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00005904626,0.00014280701,0.09832931,0.0014022123,0.00009048343,0.0048498525,0.014724153,0.00022190876,0.00016314689,0.024458263,0.4162081,0.43935072],"study_design_scores_gemma":[0.000027957401,0.00027808582,0.06465632,0.005028243,0.00013464355,0.023645166,0.04001636,0.0002412699,0.00015549801,0.024643874,0.84108716,0.00008544137],"about_ca_topic_score_codex":0.01810487,"about_ca_topic_score_gemma":0.047726247,"teacher_disagreement_score":0.01810487,"about_ca_system_score_codex":0.0025050712,"about_ca_system_score_gemma":0.007084776,"threshold_uncertainty_score":0.035999},"labels":[],"label_agreement":null},{"id":"W4403604711","doi":"10.58931/cot.2024.1221","title":"Current Uses and Pitfalls of Liquid Biopsy in NSCLC","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Princess Margaret Cancer Foundation; American Society of Clinical Oncology; International Association for the Study of Lung Cancer","keywords":"Liquid biopsy; Biopsy; Current (fluid); Medicine; Radiology; Medical physics; Internal medicine; Cancer; Physics","score_opus":0.011203312767678752,"score_gpt":0.2805186838250549,"score_spread":0.26931537105737613,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403604711","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.019190012,0.86827606,0.02534425,0.07107793,0.002978034,0.00008340394,0.00017361932,0.00048330912,0.012393291],"genre_scores_gemma":[0.25801075,0.63156986,0.062003512,0.033288617,0.011133648,0.00017296488,0.0003421336,0.00035056518,0.003127966],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.98540545,0.0053852894,0.0022804618,0.001117614,0.005384275,0.0004268376],"domain_scores_gemma":[0.9524344,0.03136454,0.0036977339,0.0017362849,0.009633429,0.001133571],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.024043553,0.0007918752,0.0013245802,0.003817307,0.0010549417,0.0040012244,0.0026415475,0.0029133789,0.0012195726],"category_scores_gemma":[0.04649984,0.0007111555,0.0008728082,0.002063966,0.0053128474,0.0042352984,0.0018267889,0.003837823,0.0017545118],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0003462947,0.00006437659,0.035101067,0.0024081864,0.00009443274,0.00456281,0.0010743327,0.0011726897,0.0033087297,0.004796043,0.030730944,0.9163401],"study_design_scores_gemma":[0.00008412138,0.00069236,0.07288522,0.020412538,0.0006966093,0.0894233,0.008557164,0.013240229,0.019329896,0.0529234,0.72132504,0.00043018605],"about_ca_topic_score_codex":0.0061588613,"about_ca_topic_score_gemma":0.012484795,"teacher_disagreement_score":0.024043553,"about_ca_system_score_codex":0.002122659,"about_ca_system_score_gemma":0.0020469753,"threshold_uncertainty_score":0.12715596},"labels":[],"label_agreement":null},{"id":"W4403604822","doi":"10.58931/cot.2024.1224","title":"An Evolving Paradigm in Borderline Resectable and Locally Advanced Pancreatic Cancer: Current Strategies and Opportunities for the Future","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Pancreatic and Hepatic Oncology Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Current (fluid); Medicine; Pancreatic cancer; Cancer; Intensive care medicine; Internal medicine; Engineering; Electrical engineering","score_opus":0.05318225327021265,"score_gpt":0.38340732239535136,"score_spread":0.3302250691251387,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403604822","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00047206183,0.98277885,0.0006990741,0.012413224,0.0016380098,0.00000886645,0.000022521861,0.00004272839,0.0019246185],"genre_scores_gemma":[0.0032159223,0.9848337,0.0010382178,0.006395073,0.003165913,0.000026847494,0.00005331456,0.000013330293,0.0012576035],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9995696,0.00013953916,0.000062900086,0.00006563656,0.000100147,0.00006217012],"domain_scores_gemma":[0.998757,0.0005973911,0.00012465031,0.000036355523,0.0003100915,0.00017461856],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016916244,0.0005463913,0.0009978204,0.0011680429,0.00044441808,0.001792417,0.0009499951,0.0017784501,0.002909192],"category_scores_gemma":[0.0019934827,0.00017609145,0.0007908865,0.0010019237,0.0012003799,0.0035853346,0.0010791508,0.004147681,0.0014080617],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001679512,0.00011050765,0.0005746075,0.008994467,0.00007970765,0.0007422633,0.000392398,0.00061989296,0.0018560468,0.014972396,0.11111441,0.86037534],"study_design_scores_gemma":[0.000022291995,0.0001937404,0.0007667838,0.0037922817,0.00007654033,0.0023129913,0.00038538149,0.0002661904,0.00027761536,0.007131605,0.9847414,0.00003318727],"about_ca_topic_score_codex":0.0009614877,"about_ca_topic_score_gemma":0.002426705,"teacher_disagreement_score":0.002909192,"about_ca_system_score_codex":0.0012422239,"about_ca_system_score_gemma":0.0016204602,"threshold_uncertainty_score":0.009732187},"labels":[],"label_agreement":null},{"id":"W4403604899","doi":"10.58931/cot.2024.1222","title":"From Intractable to Treatable: Milestones and Horizons in the Management of HER2+ Breast Cancer","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre; University Health Network","funders":"","keywords":"Breast cancer; Medicine; New horizons; Cancer; General surgery; Internal medicine; Engineering","score_opus":0.027025459900487908,"score_gpt":0.37526584115896766,"score_spread":0.3482403812584798,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403604899","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0022108273,0.603322,0.00383108,0.35812303,0.014849792,0.000051591425,0.00015625625,0.00016385435,0.017291676],"genre_scores_gemma":[0.030154219,0.8076773,0.00628631,0.12096973,0.022923864,0.00009977695,0.0003751682,0.00011426695,0.011399328],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99876547,0.0004205368,0.00010118306,0.00013698816,0.0004263774,0.00014940857],"domain_scores_gemma":[0.99773335,0.00060382,0.00021732123,0.00008070972,0.0005413886,0.0008234185],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027966565,0.00068262126,0.00074890204,0.0008527137,0.000928487,0.002999823,0.0012584818,0.0025580893,0.009611985],"category_scores_gemma":[0.0054417495,0.00018617924,0.0005763768,0.0005739527,0.002124764,0.0060003526,0.0029903175,0.009983575,0.003194473],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00022013535,0.00022492264,0.00079553545,0.002293408,0.000037106733,0.00067919557,0.0005252545,0.00044043554,0.0010943883,0.030386198,0.41821232,0.5450911],"study_design_scores_gemma":[0.00004620308,0.000221848,0.0008529457,0.0040495335,0.00002879403,0.0016674054,0.0006265174,0.0002673133,0.0002695237,0.024245277,0.9676916,0.000032970922],"about_ca_topic_score_codex":0.0014282593,"about_ca_topic_score_gemma":0.004843989,"teacher_disagreement_score":0.009611985,"about_ca_system_score_codex":0.0020639345,"about_ca_system_score_gemma":0.003302099,"threshold_uncertainty_score":0.032155335},"labels":[],"label_agreement":null},{"id":"W4403604925","doi":"10.58931/cot.2024.1220","title":"Current and Emerging Treatment Options for HER2‑Positive Gastroesophageal Cancer","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Gastric Cancer Management and Outcomes","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Medicine; Cancer; Current (fluid); Internal medicine; Intensive care medicine; Oncology; Oceanography; Geology","score_opus":0.0256144487643433,"score_gpt":0.3538786207820933,"score_spread":0.32826417201775,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403604925","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0015374946,0.98049796,0.00087118713,0.008465076,0.00058799016,0.000019849513,0.00008211623,0.00003208972,0.007906241],"genre_scores_gemma":[0.012591594,0.97754616,0.0019286543,0.0034927668,0.0010937054,0.000039131177,0.00029974815,0.000010107348,0.0029981164],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998234,0.000033924098,0.000020663392,0.000021978916,0.00007102009,0.000029088273],"domain_scores_gemma":[0.9997893,0.00006118271,0.000036956128,0.00000510202,0.000068097106,0.000039478047],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00052645046,0.00035867625,0.00047417625,0.00069091574,0.0003130856,0.0007236045,0.00055532006,0.0005845454,0.005056948],"category_scores_gemma":[0.00066483306,0.0000836994,0.00051882694,0.00054253027,0.00031435944,0.00091715046,0.00052899367,0.0017144596,0.0009999331],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001173108,0.000091935995,0.0006211663,0.0036881994,0.00004366112,0.00047163904,0.000092058996,0.00038110497,0.0015127443,0.0050786817,0.044771582,0.94312984],"study_design_scores_gemma":[0.000088383305,0.00025621578,0.0022299646,0.0036890763,0.00013549309,0.0020013633,0.00021758149,0.00030825514,0.0005309734,0.005001939,0.985521,0.000019808744],"about_ca_topic_score_codex":0.0021384472,"about_ca_topic_score_gemma":0.0101981945,"teacher_disagreement_score":0.005056948,"about_ca_system_score_codex":0.00084205647,"about_ca_system_score_gemma":0.0011268663,"threshold_uncertainty_score":0.01691717},"labels":[],"label_agreement":null},{"id":"W4403961654","doi":"10.58931/cot.2024.1326","title":"Prostate-specific Membrane Antigen (PSMA): A Diagnostic and Therapeutic Target in Advanced Prostate Cancer","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Health Sciences Centre; University of Toronto; Sunnybrook Health Science Centre","funders":"","keywords":"Glutamate carboxypeptidase II; Prostate cancer; Prostate-specific antigen; Medicine; Prostate; Antigen; Cancer; Cancer research; Oncology; Internal medicine; Immunology","score_opus":0.021559119780432432,"score_gpt":0.32790311552643636,"score_spread":0.3063439957460039,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403961654","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0018346873,0.98928726,0.0011539441,0.0031484799,0.00039210363,0.000016671851,0.00006067563,0.000035871242,0.0040702317],"genre_scores_gemma":[0.018231394,0.9755398,0.0015461296,0.0010528426,0.0006426599,0.000018851088,0.00011729541,0.000005540439,0.002845561],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997485,0.000050744275,0.000017417879,0.000032231652,0.000115384166,0.00003571062],"domain_scores_gemma":[0.9998536,0.00004290812,0.000023710018,0.0000041382937,0.00004851788,0.000027107064],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005983915,0.00038605457,0.000614183,0.0010214463,0.0003157444,0.00089729537,0.00038253306,0.00082425,0.0018203597],"category_scores_gemma":[0.00046150445,0.00014052432,0.000268863,0.0010122258,0.0004590829,0.0008541254,0.00050570304,0.0013585718,0.0011287357],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023492395,0.000107819134,0.0012571486,0.00667242,0.00006542537,0.0007625384,0.00017899943,0.0007363296,0.025947824,0.0137526505,0.0491961,0.9010879],"study_design_scores_gemma":[0.00002309427,0.00030977093,0.0021976556,0.00085717987,0.00006696845,0.0034069426,0.00011241533,0.00033803988,0.008103969,0.003262898,0.9812899,0.000031121577],"about_ca_topic_score_codex":0.0022212258,"about_ca_topic_score_gemma":0.004268123,"teacher_disagreement_score":0.0022212258,"about_ca_system_score_codex":0.001031361,"about_ca_system_score_gemma":0.0014372392,"threshold_uncertainty_score":0.0074830055},"labels":[],"label_agreement":null},{"id":"W4403961830","doi":"10.58931/cot.2024.1329","title":"Antibody-drug Conjugates in The Management of Advanced Urothelial Carcinoma","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Bladder and Urothelial Cancer Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Urothelial carcinoma; Antibody; Drug; Antibody-drug conjugate; Medicine; Conjugate; Carcinoma; Cancer research; Internal medicine; Pharmacology; Immunology; Monoclonal antibody; Cancer; Bladder cancer","score_opus":0.014360824321639591,"score_gpt":0.31596838758125917,"score_spread":0.30160756325961957,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403961830","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.001885406,0.99418384,0.00068170886,0.0005620664,0.00034972845,0.000015879668,0.0000276177,0.000017549102,0.002276176],"genre_scores_gemma":[0.021634962,0.97352004,0.0012347432,0.0008223692,0.00044106727,0.00003374111,0.00010259458,0.000006333833,0.002204041],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997992,0.000056583158,0.000024576433,0.00002390386,0.000070271424,0.000025483727],"domain_scores_gemma":[0.9998822,0.00004646532,0.000022526596,0.000004027615,0.0000310867,0.000013608312],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00047355334,0.00032438946,0.0004923919,0.00066555705,0.0001642802,0.0005125754,0.00033718225,0.0006514032,0.0017216556],"category_scores_gemma":[0.00043156775,0.00013403298,0.0003023014,0.0004647326,0.00021627273,0.00060777756,0.0003996363,0.0011698116,0.0007391477],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00027112055,0.00016850994,0.00042470754,0.009795107,0.00011032471,0.00064109603,0.0001341806,0.0013948645,0.017188117,0.007296206,0.027594961,0.93498075],"study_design_scores_gemma":[0.000062728825,0.0006524741,0.0008394077,0.0010996334,0.000083831,0.0024303535,0.000048427984,0.0004027021,0.006596508,0.001871729,0.9858905,0.000021840446],"about_ca_topic_score_codex":0.00037850437,"about_ca_topic_score_gemma":0.00096888887,"teacher_disagreement_score":0.0017216556,"about_ca_system_score_codex":0.00035379847,"about_ca_system_score_gemma":0.00035579,"threshold_uncertainty_score":0.0057594776},"labels":[],"label_agreement":null},{"id":"W4403961868","doi":"10.58931/cot.2024.1328","title":"Tailored Approaches and Patient-centered Care: The Current Landscape of Neoadjuvant Therapy in Rectal Cancer","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Colorectal Cancer Surgical Treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":false,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"","funders":"","keywords":"Colorectal cancer; Medicine; Current (fluid); Neoadjuvant therapy; Oncology; Cancer; Intensive care medicine; General surgery; Internal medicine; Breast cancer; Engineering","score_opus":0.04670660681887358,"score_gpt":0.31028578139431917,"score_spread":0.2635791745754456,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403961868","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0019993372,0.89384705,0.0033162083,0.084646754,0.0015786004,0.00006409143,0.00004676712,0.000061974744,0.014439193],"genre_scores_gemma":[0.02740384,0.9346938,0.008529098,0.02545903,0.0021921473,0.00016465825,0.000098647375,0.000025308564,0.0014333643],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9964426,0.0020179788,0.00024902547,0.00021832448,0.00089082203,0.00018137506],"domain_scores_gemma":[0.99497545,0.002944307,0.00055356295,0.00011234866,0.0008412853,0.0005730338],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0041077947,0.0004616252,0.000855915,0.0005882742,0.00081811205,0.002906995,0.0012685873,0.0014545677,0.0028830322],"category_scores_gemma":[0.007797156,0.00017271396,0.0006316391,0.000993009,0.002064739,0.0021387038,0.0023328552,0.0043193363,0.00060464797],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00012151548,0.00011435427,0.0012043763,0.014713124,0.00015295202,0.0003005891,0.0016040796,0.00083443645,0.00053452904,0.027903683,0.057325132,0.89519125],"study_design_scores_gemma":[0.00008861907,0.00032132224,0.0047826516,0.021688653,0.00014645119,0.0010734757,0.0015276064,0.00054836454,0.00035413634,0.022552684,0.9468406,0.00007553168],"about_ca_topic_score_codex":0.0068153385,"about_ca_topic_score_gemma":0.021826109,"teacher_disagreement_score":0.0068153385,"about_ca_system_score_codex":0.0039777486,"about_ca_system_score_gemma":0.008006201,"threshold_uncertainty_score":0.028860688},"labels":[],"label_agreement":null},{"id":"W4403961907","doi":"10.58931/cot.2024.1325","title":"First-line Treatment Selection for Advanced Hepatocellular Carcinoma","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Hepatocellular Carcinoma Treatment and Prognosis","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Juravinski Cancer Centre; McMaster University","funders":"","keywords":"Hepatocellular carcinoma; Selection (genetic algorithm); Line (geometry); Oncology; Medicine; Internal medicine; Computer science; Artificial intelligence; Mathematics","score_opus":0.05903454439788217,"score_gpt":0.2902703179108537,"score_spread":0.23123577351297156,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403961907","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.48378307,0.2065271,0.026075846,0.024457844,0.004594941,0.0013030022,0.014339623,0.0013349552,0.23758356],"genre_scores_gemma":[0.9076834,0.036448017,0.007241839,0.009957178,0.002183092,0.0006118579,0.016548738,0.00031067926,0.019015232],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.999816,0.0000319728,0.000023974877,0.00002804169,0.000052650023,0.000047421752],"domain_scores_gemma":[0.9996593,0.00004233287,0.000057114095,0.000021558571,0.00007125781,0.00014841222],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00028573142,0.00021757596,0.0006137959,0.0006202866,0.00048181915,0.0006138114,0.00020159282,0.00041538192,0.0113619715],"category_scores_gemma":[0.001092955,0.000080383346,0.00079174235,0.00045484002,0.00016988617,0.0005422653,0.0002988167,0.0007541085,0.002607263],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0035562878,0.00033719421,0.14021209,0.0013364778,0.000299614,0.0049668415,0.0002617701,0.0018598897,0.010751443,0.0029448043,0.12087678,0.7125969],"study_design_scores_gemma":[0.00089433027,0.0035341538,0.46636292,0.0031266257,0.00080256816,0.04058798,0.00094759825,0.0042455066,0.013614856,0.008386106,0.4573033,0.0001940386],"about_ca_topic_score_codex":0.001537043,"about_ca_topic_score_gemma":0.0049484833,"teacher_disagreement_score":0.0113619715,"about_ca_system_score_codex":0.0008870507,"about_ca_system_score_gemma":0.00049444835,"threshold_uncertainty_score":0.038009644},"labels":[],"label_agreement":null},{"id":"W4403962313","doi":"10.58931/cot.2024.1327","title":"Breast Cancer Survivorship","year":2024,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Cancer-related cognitive impairment studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Calgary","funders":"","keywords":"Survivorship curve; Cancer survivorship; Breast cancer; Cancer; Oncology; Medicine; Internal medicine","score_opus":0.022832134160178454,"score_gpt":0.3269969300789985,"score_spread":0.30416479591882006,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4403962313","genre_codex":"other","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.082084924,0.08239545,0.0023822854,0.051082205,0.0037732648,0.0015255017,0.05946989,0.0006739494,0.71661246],"genre_scores_gemma":[0.61027026,0.11002515,0.0039088926,0.019663658,0.0018634513,0.00092602836,0.038287774,0.00015337889,0.21490145],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99866784,0.00010909849,0.000049332415,0.0000904875,0.00067548006,0.0004078175],"domain_scores_gemma":[0.9977196,0.00014842828,0.00016179626,0.00010794772,0.0013150462,0.0005471634],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007559021,0.00022241635,0.00045919427,0.0013351135,0.002977537,0.0012850661,0.0009366,0.00064446795,0.038600646],"category_scores_gemma":[0.003883672,0.00010655144,0.000510059,0.0021259896,0.00041215797,0.00064177014,0.0013219486,0.00097101304,0.0054932483],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008364383,0.00012401833,0.07472385,0.0008366406,0.00008396239,0.00038242072,0.0011031177,0.00008474464,0.00025949808,0.0040986324,0.41187984,0.50633955],"study_design_scores_gemma":[0.000023577804,0.00009115041,0.13502069,0.0012913399,0.00013270213,0.0010972176,0.0018974262,0.00010318593,0.00016490307,0.0013807758,0.85876185,0.000035228994],"about_ca_topic_score_codex":0.5010395,"about_ca_topic_score_gemma":0.6877332,"teacher_disagreement_score":0.5010395,"about_ca_system_score_codex":0.0048760446,"about_ca_system_score_gemma":0.01695269,"threshold_uncertainty_score":0.9962463},"labels":[],"label_agreement":null},{"id":"W4409361702","doi":"10.58931/cot.2025.2131","title":"Clinical Considerations for the Management of Advanced PD-L1 ≥50% Non-small Cell Lung Cancer In 2025: Should All Patients Be Treated the Same?","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Cancer Immunotherapy and Biomarkers","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Centre Hospitalier de l’Université de Montréal; Université de Montréal","funders":"","keywords":"Lung cancer; Medicine; Intensive care medicine; Cancer; Oncology; Internal medicine","score_opus":0.04781192108716303,"score_gpt":0.3763830102409679,"score_spread":0.32857108915380484,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409361702","genre_codex":"commentary","genre_gemma":"commentary","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"commentary","genre_consensus":"commentary","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.006872105,0.15671764,0.0029213463,0.80569834,0.013982882,0.0001624497,0.00023729706,0.00015319823,0.013254739],"genre_scores_gemma":[0.11746422,0.16506185,0.01653668,0.61320984,0.075055905,0.0009128363,0.0009872608,0.00018032744,0.010591036],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9979863,0.00079714914,0.00033239156,0.00021841012,0.00043899583,0.0002267496],"domain_scores_gemma":[0.99310654,0.0018200475,0.00063585147,0.00016513404,0.0019062588,0.0023661794],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004628156,0.00045124782,0.0019906708,0.00053486566,0.0020994623,0.0039043096,0.0018144551,0.006043591,0.005388364],"category_scores_gemma":[0.013647397,0.0002507611,0.0015075598,0.00043002958,0.0015345279,0.0048923814,0.0022527904,0.010939294,0.0027271241],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0010607998,0.0005569931,0.008010191,0.001464801,0.00016911472,0.0017453793,0.000674134,0.00073207123,0.0011846238,0.009779224,0.47337702,0.5012456],"study_design_scores_gemma":[0.0010134216,0.0019534603,0.016950991,0.012109329,0.0003305799,0.006879283,0.003230471,0.0011016246,0.00047815416,0.04574326,0.9099571,0.00025229692],"about_ca_topic_score_codex":0.0027509138,"about_ca_topic_score_gemma":0.008556122,"teacher_disagreement_score":0.006043591,"about_ca_system_score_codex":0.0022921413,"about_ca_system_score_gemma":0.0059662387,"threshold_uncertainty_score":0.02447629},"labels":[],"label_agreement":null},{"id":"W4409361713","doi":"10.58931/cot.2025.2132","title":"Current Approaches and Future Directions for the Treatment of Solid Tumour Brain Metastases","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Brain Metastases and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto","funders":"National Cancer Institute; NRG Oncology; Breast Cancer Alliance","keywords":"Current (fluid); Medicine; Intensive care medicine; Oncology; Geology; Oceanography","score_opus":0.04357760434610908,"score_gpt":0.33419747797350463,"score_spread":0.29061987362739555,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409361713","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0012149977,0.9461286,0.004276399,0.03560415,0.0028324379,0.000074043244,0.00020093018,0.0002149276,0.009453546],"genre_scores_gemma":[0.0092597995,0.95861614,0.009889939,0.01268886,0.003742425,0.00021853847,0.00060747145,0.000055462657,0.0049214386],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989716,0.00028798304,0.00010067046,0.00016770324,0.00029007072,0.00018202903],"domain_scores_gemma":[0.99614894,0.0016086228,0.00032382883,0.00013576944,0.0012669154,0.0005158952],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0037769293,0.0008000363,0.0011121518,0.001345854,0.00047364883,0.0022111696,0.002019702,0.003504123,0.019487033],"category_scores_gemma":[0.0039473316,0.00026814695,0.0014357667,0.0010523956,0.0015032358,0.0032380372,0.0012658312,0.0053327517,0.0057571153],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0004500471,0.0005156146,0.0006928302,0.0068705813,0.00011454557,0.00036781936,0.00015747629,0.0011494164,0.002561129,0.0152995,0.07225696,0.8995641],"study_design_scores_gemma":[0.00016282072,0.00083891535,0.0012169864,0.005224082,0.00019018486,0.0007913299,0.0003793447,0.0008949765,0.0007473649,0.018266326,0.9712305,0.00005722302],"about_ca_topic_score_codex":0.00219266,"about_ca_topic_score_gemma":0.0050522885,"teacher_disagreement_score":0.019487033,"about_ca_system_score_codex":0.0013464015,"about_ca_system_score_gemma":0.0042072814,"threshold_uncertainty_score":0.06519061},"labels":[],"label_agreement":null},{"id":"W4409361743","doi":"10.58931/cot.2025.2130","title":"The Role of ctDNA in Breast Cancer: Prognosis and Clinical Utility","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Cancer Genomics and Diagnostics","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"National Cancer Institute","keywords":"Breast cancer; Oncology; Medicine; Internal medicine; Cancer","score_opus":0.007787703013319037,"score_gpt":0.297753369462649,"score_spread":0.28996566644933,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409361743","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.04678202,0.9089325,0.0055095265,0.021983985,0.0009417539,0.000050701754,0.0013855738,0.00011281766,0.014301108],"genre_scores_gemma":[0.49184534,0.483947,0.012174668,0.004353713,0.0023859153,0.000060426846,0.0011872437,0.00004965578,0.0039961273],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9989467,0.0003101732,0.000103977276,0.00014347605,0.0004403666,0.000055373053],"domain_scores_gemma":[0.99620986,0.0015010096,0.00079570204,0.00012498331,0.0011350786,0.000233366],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0025814837,0.0004475948,0.00053401623,0.001821504,0.00035500192,0.0020901682,0.00051054376,0.00090355997,0.0015427353],"category_scores_gemma":[0.008910326,0.00016156984,0.00023532378,0.0024364893,0.0011762147,0.0009904702,0.0005686545,0.000988765,0.0007537607],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0006430854,0.00006582695,0.3078257,0.0014698943,0.00017350767,0.0005583393,0.00034508097,0.0011113946,0.0051768734,0.004884173,0.013590091,0.6641561],"study_design_scores_gemma":[0.00009888777,0.0011936877,0.5798403,0.007715227,0.0007724662,0.0139822215,0.0016717211,0.006366234,0.0129127465,0.027159678,0.34797758,0.0003093158],"about_ca_topic_score_codex":0.012322269,"about_ca_topic_score_gemma":0.01053921,"teacher_disagreement_score":0.012322269,"about_ca_system_score_codex":0.0014515311,"about_ca_system_score_gemma":0.0014469933,"threshold_uncertainty_score":0.024501085},"labels":[],"label_agreement":null},{"id":"W4409362115","doi":"10.58931/cot.2025.2134","title":"Advances in Adjuvant Therapy for High-Risk Breast Cancer: A Canadian Clinical Approach","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Saskatchewan Cancer Agency; University of Saskatchewan","funders":"","keywords":"Breast cancer; Adjuvant therapy; Medicine; Oncology; Adjuvant; Internal medicine; Cancer","score_opus":0.011886230167647342,"score_gpt":0.3271848254345535,"score_spread":0.3152985952669062,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4409362115","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0017429298,0.91808873,0.0007600338,0.05436671,0.0019299706,0.0000964528,0.00043328822,0.000038849485,0.022543058],"genre_scores_gemma":[0.011706212,0.97506577,0.0020127345,0.005869635,0.0007394004,0.00004343799,0.0003329962,0.000014082696,0.0042157373],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99899215,0.00015374624,0.00007911197,0.00008060687,0.00056593993,0.00012846653],"domain_scores_gemma":[0.9964623,0.00025964523,0.00014312782,0.00004324595,0.0026661928,0.00042545627],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0027719357,0.0006497038,0.00079245114,0.0022015937,0.0016121024,0.0020293002,0.0009960106,0.0010137922,0.006243448],"category_scores_gemma":[0.0035390565,0.00018864793,0.00052395294,0.0043175425,0.0009887208,0.00090226316,0.0010955678,0.002173769,0.0011090244],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00026922397,0.00011103243,0.004990017,0.005928994,0.00011834297,0.00054078427,0.00044619045,0.0005738892,0.0022036452,0.015736131,0.17636114,0.79272056],"study_design_scores_gemma":[0.00008838799,0.00010840641,0.008060746,0.0049241255,0.00020349576,0.0005936421,0.00036145624,0.00021267253,0.0003876774,0.002294638,0.9827256,0.000039091236],"about_ca_topic_score_codex":0.7250814,"about_ca_topic_score_gemma":0.88184434,"teacher_disagreement_score":0.27491862,"about_ca_system_score_codex":0.021018427,"about_ca_system_score_gemma":0.0650057,"threshold_uncertainty_score":0.5530753},"labels":[],"label_agreement":null},{"id":"W4413382302","doi":"10.58931/cot.2025.2236","title":"Perioperative Treatment Strategies for Lung Cancer in 2025: A Paradigm Shift","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Lung Cancer Diagnosis and Treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Quebec - Clinical Research Organization in Cancer; Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Perioperative; Paradigm shift; Intensive care medicine; Lung cancer; Cancer; Medicine; Oncology; Internal medicine; Anesthesia; Philosophy; Epistemology","score_opus":0.020118020745769693,"score_gpt":0.3727308848975044,"score_spread":0.3526128641517347,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413382302","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0025778504,0.8492399,0.004461917,0.1302942,0.0049255216,0.000045336645,0.00006949918,0.0000639853,0.008321797],"genre_scores_gemma":[0.03192229,0.8906943,0.012277726,0.051503405,0.009967618,0.00017043258,0.00018888086,0.000048782324,0.00322661],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99882525,0.00048674134,0.00014754625,0.00011358969,0.00031966605,0.00010719743],"domain_scores_gemma":[0.99719465,0.0014108255,0.00032168624,0.00006313408,0.0006691744,0.00034053493],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004958355,0.00053327205,0.000926688,0.0007893731,0.00075147644,0.002731893,0.0010327572,0.001931302,0.0031852636],"category_scores_gemma":[0.004181585,0.00018833196,0.0010130439,0.00048023454,0.0013623104,0.0036349264,0.001794148,0.005191343,0.0011641457],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00032242638,0.0002069591,0.0018391617,0.0072926693,0.00018476653,0.0005205643,0.0005644885,0.0011581668,0.0019129849,0.03704994,0.06173053,0.88721746],"study_design_scores_gemma":[0.00011939345,0.00069537654,0.00275673,0.011168042,0.00023239532,0.0015794279,0.0015341245,0.00057541934,0.00085175305,0.026625156,0.9537924,0.00006974972],"about_ca_topic_score_codex":0.0027884752,"about_ca_topic_score_gemma":0.011604645,"teacher_disagreement_score":0.004958355,"about_ca_system_score_codex":0.002765069,"about_ca_system_score_gemma":0.006856212,"threshold_uncertainty_score":0.026222646},"labels":[],"label_agreement":null},{"id":"W4413382855","doi":"10.58931/cot.2025.2239","title":"Small-Cell Lung Cancer: Integration of Radiation and Immunotherapy for All Stages","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Lung Cancer Research Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Hôpital Charles-Le Moyne","funders":"","keywords":"Immunotherapy; Lung cancer; Cancer; Medicine; Radiation therapy; Oncology; Cancer research; Internal medicine","score_opus":0.025115515050603034,"score_gpt":0.3782479123245323,"score_spread":0.35313239727392925,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413382855","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0011079968,0.9876873,0.0007382462,0.003937384,0.00050554844,0.000027580629,0.000017612925,0.000017328784,0.0059610847],"genre_scores_gemma":[0.010698262,0.98257494,0.001985096,0.0013471196,0.0012793924,0.000023097136,0.000042755142,0.0000076279316,0.0020417257],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99954957,0.0001334991,0.000040308565,0.000032640663,0.00019606411,0.00004795607],"domain_scores_gemma":[0.99963784,0.000136497,0.000047041096,0.000014026256,0.00010517315,0.00005934479],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0015065653,0.00036674808,0.00054117816,0.0009123977,0.00037785183,0.0008827236,0.00038855843,0.0005461619,0.0021454867],"category_scores_gemma":[0.0008362465,0.00010046498,0.00043924147,0.0007375315,0.00044166198,0.0009909936,0.000670866,0.00087340974,0.00049083657],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00008666822,0.00006019476,0.001044741,0.004628854,0.00005895634,0.00024130085,0.00012523551,0.00018019162,0.0037546386,0.005349643,0.013596241,0.97087336],"study_design_scores_gemma":[0.000040699404,0.00063634716,0.0067365733,0.0030078741,0.00018019247,0.0023180647,0.00024065551,0.0001018407,0.0016958265,0.0037394618,0.98127365,0.00002888432],"about_ca_topic_score_codex":0.003899632,"about_ca_topic_score_gemma":0.020223932,"teacher_disagreement_score":0.003899632,"about_ca_system_score_codex":0.0010391214,"about_ca_system_score_gemma":0.0034761853,"threshold_uncertainty_score":0.007967591},"labels":[],"label_agreement":null},{"id":"W4413417222","doi":"10.58931/cot.2025.2235","title":"Antibody-Drug Conjugates in Breast Cancer: Current Landscape and Future Targets","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"HER2/EGFR in Cancer Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":true,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; Mount Sinai Hospital","funders":"University of Toronto; University of Ottawa","keywords":"Antibody-drug conjugate; Breast cancer; Antibody; Drug; Conjugate; Medicine; Cancer; Cancer drugs; Current (fluid); Immunology; Cancer research; Pharmacology; Monoclonal antibody; Internal medicine; Engineering","score_opus":0.011839490796647313,"score_gpt":0.3703987486551005,"score_spread":0.35855925785845316,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413417222","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.00038074984,0.989813,0.00027791827,0.006648741,0.0004922732,0.000007770282,0.000021934055,0.00001826592,0.0023393894],"genre_scores_gemma":[0.0035998176,0.99099475,0.00063872273,0.0022511887,0.00084633846,0.000011779732,0.00004708326,0.0000072836365,0.0016029887],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9993368,0.0001782897,0.000049906514,0.00006435204,0.00025340606,0.000117230724],"domain_scores_gemma":[0.9987074,0.0004325153,0.00009902135,0.000028237127,0.0005137383,0.00021900191],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002907534,0.0005077832,0.0008079858,0.0013785424,0.0005729625,0.0018792821,0.00074459426,0.0014613096,0.0055319765],"category_scores_gemma":[0.0019331567,0.00022959556,0.0003598872,0.0020644758,0.0014047681,0.002904983,0.0009150229,0.002215328,0.0017366251],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0001806344,0.00009793032,0.0004889214,0.0036381192,0.000027068156,0.00031200275,0.00015031177,0.00063599437,0.002021023,0.014176556,0.088123724,0.8901476],"study_design_scores_gemma":[0.000040129944,0.00022801978,0.00068937324,0.0013608556,0.000033870856,0.0007415557,0.00014771863,0.00024050064,0.00058708875,0.0044605127,0.9914487,0.00002169097],"about_ca_topic_score_codex":0.010145557,"about_ca_topic_score_gemma":0.036094464,"teacher_disagreement_score":0.010145557,"about_ca_system_score_codex":0.003563772,"about_ca_system_score_gemma":0.0046583726,"threshold_uncertainty_score":0.02585715},"labels":[],"label_agreement":null},{"id":"W4413417257","doi":"10.58931/cot.2025.2237","title":"Treatment of Neuroendocrine Tumours: Approach of GEP-NETS","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Neuroendocrine Tumor Research Advances","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Centre Hospitalier de l’Université de Montréal","funders":"","keywords":"Neuroendocrine tumors; Computer science; Internal medicine; Medicine","score_opus":0.025550826043837887,"score_gpt":0.3455222686199967,"score_spread":0.3199714425761588,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413417257","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.02185716,0.8503886,0.021285264,0.032589238,0.0029542248,0.00020092416,0.00021954018,0.00013199227,0.07037308],"genre_scores_gemma":[0.19473551,0.7331957,0.030852633,0.013728332,0.0054901983,0.00017552589,0.0005327693,0.00009814554,0.02119118],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9998242,0.000041421383,0.000015131405,0.000024597475,0.000071136266,0.000023444205],"domain_scores_gemma":[0.99988437,0.000021197959,0.000021099255,0.000005475682,0.000030491894,0.000037304406],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003595023,0.0003490853,0.0003859942,0.00057051686,0.00039367692,0.00069537753,0.00039510333,0.0004546478,0.0017897605],"category_scores_gemma":[0.00056819426,0.0000697244,0.00038609965,0.00047141337,0.00038167377,0.0006542201,0.00058379734,0.001402869,0.00069497846],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00023492255,0.00014098747,0.0046104733,0.0028299354,0.00011361228,0.004279545,0.00025025388,0.0016711283,0.009428707,0.014749238,0.033319138,0.928372],"study_design_scores_gemma":[0.00014086936,0.00065577007,0.015528671,0.002637968,0.00015473171,0.042701878,0.00043311462,0.001264412,0.003941151,0.016307298,0.91618097,0.000053129763],"about_ca_topic_score_codex":0.003044749,"about_ca_topic_score_gemma":0.011293254,"teacher_disagreement_score":0.003044749,"about_ca_system_score_codex":0.0014433764,"about_ca_system_score_gemma":0.0014441436,"threshold_uncertainty_score":0.010472417},"labels":[],"label_agreement":null},{"id":"W4413417272","doi":"10.58931/cot.2025.2238","title":"Management of Stage I–II Testicular Germ Cell Tumours: Current Treatment Paradigm and Future Perspectives","year":2025,"lang":"en","type":"article","venue":"Canadian oncology today.","topic":"Testicular diseases and treatments","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"","keywords":"Germ cell; Stage (stratigraphy); Current (fluid); Medicine; Cancer research; Biology; Engineering; Genetics","score_opus":0.00975194719520876,"score_gpt":0.29571720501908866,"score_spread":0.2859652578238799,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4413417272","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0013595803,0.9784546,0.0009008603,0.0145314,0.0006599754,0.00002166966,0.000059465685,0.000023331511,0.0039892313],"genre_scores_gemma":[0.01574501,0.974462,0.0029423784,0.004234032,0.001557077,0.000037166123,0.00015304929,0.000011168801,0.0008581044],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99947685,0.00014756608,0.0000744406,0.000060400187,0.00016307925,0.00007761827],"domain_scores_gemma":[0.9988238,0.0004414489,0.00015346488,0.000022887416,0.00042266666,0.00013561928],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0016196381,0.00040398343,0.0008806352,0.0008563681,0.00055003486,0.0014943342,0.0010600606,0.0009209276,0.00307165],"category_scores_gemma":[0.002612593,0.00013001694,0.00070758065,0.0006473958,0.00086487154,0.0014572346,0.0007628247,0.0022765798,0.00064253],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0002222929,0.00009505632,0.0021887277,0.008776798,0.00012676744,0.0006771477,0.00029617114,0.0011044081,0.0008272703,0.0077467333,0.039030947,0.9389077],"study_design_scores_gemma":[0.00015012758,0.0007989875,0.0062747234,0.026419712,0.0004652042,0.0046461746,0.0015238144,0.00096975476,0.00067074754,0.01717008,0.94082856,0.00008200121],"about_ca_topic_score_codex":0.009636218,"about_ca_topic_score_gemma":0.03217232,"teacher_disagreement_score":0.009636218,"about_ca_system_score_codex":0.002215325,"about_ca_system_score_gemma":0.004008833,"threshold_uncertainty_score":0.01916027},"labels":[],"label_agreement":null},{"id":"W4415934922","doi":"10.58931/cot.2025.2342","title":"Original Research: Biomarker Testing in a Canadian Centre for Patients with Non‑small Cell Lung Cancer: Assessing Residual Risks","year":2025,"lang":"","type":"article","venue":"Canadian oncology today.","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"University of Manitoba; Manitoba Health; Lunenfeld-Tanenbaum Research Institute; Occupational Cancer Research Centre; Public Health Ontario; University of Toronto; Toronto Public Health","funders":"","keywords":"ROS1; Erlotinib; Guideline; Biomarker; Lung cancer; Crizotinib; Epidermal growth factor receptor; Genetic testing; Cancer","score_opus":0.07447973931669052,"score_gpt":0.4308980292734839,"score_spread":0.35641828995679337,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415934922","genre_codex":"empirical","genre_gemma":"empirical","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"empirical","genre_consensus":"empirical","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.89844334,0.011596333,0.003982814,0.021765754,0.0006052575,0.001157689,0.016016787,0.00016159628,0.046270404],"genre_scores_gemma":[0.98702973,0.0023089086,0.0037141826,0.0024442999,0.00014469223,0.00012050074,0.0022839017,0.0000315013,0.0019220876],"study_design_codex":"observational","study_design_gemma":"observational","domain_scores_codex":[0.9952754,0.00051730924,0.00045037887,0.00062799454,0.0024229605,0.0007059884],"domain_scores_gemma":[0.98794764,0.0009418151,0.0024472498,0.00042024459,0.0061582117,0.0020849023],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002643812,0.0003972235,0.00032194075,0.0013204028,0.003025658,0.0016405252,0.0013375151,0.00051495316,0.0037556097],"category_scores_gemma":[0.012617271,0.00023387323,0.00054621894,0.0038825895,0.0010857029,0.00059978536,0.0010369157,0.0008890883,0.00046696624],"study_design_candidate":"observational","study_design_consensus":"observational","about_ca_topic_candidate":true,"about_ca_topic_consensus":true,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00015702735,0.000038739727,0.94729203,0.00031702156,0.000077502926,0.00094371306,0.0009696406,0.0002681953,0.0007550903,0.00061443576,0.015700309,0.03286625],"study_design_scores_gemma":[0.000031314645,0.00013444618,0.96679336,0.00043360205,0.00013581463,0.002377021,0.002478777,0.00074249884,0.0007251323,0.000287809,0.025806876,0.000053280808],"about_ca_topic_score_codex":0.9290063,"about_ca_topic_score_gemma":0.9600462,"teacher_disagreement_score":0.07099372,"about_ca_system_score_codex":0.03357106,"about_ca_system_score_gemma":0.0681605,"threshold_uncertainty_score":0.24357629},"labels":[],"label_agreement":null},{"id":"W4415934991","doi":"10.58931/cot.2025.2343","title":"Current Issues in the Management of Sporadic Non-clear Cell Renal Cell Carcinoma (Non-ccRCC)","year":2025,"lang":"","type":"article","venue":"Canadian oncology today.","topic":"Renal cell carcinoma treatment","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":true,"ca_institutions":"Queen's University","funders":"","keywords":"Renal cell carcinoma; Kidney cancer; Cell; Clear cell renal cell carcinoma; Carcinoma; Cancer; Clear cell","score_opus":0.015709473236864595,"score_gpt":0.28532122771388924,"score_spread":0.2696117544770246,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415934991","genre_codex":"review","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":"review","domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.0068642735,0.66507393,0.0029871378,0.292151,0.004415306,0.00008938602,0.0001917623,0.00011494634,0.028112324],"genre_scores_gemma":[0.09802067,0.81092304,0.013845697,0.051273793,0.017491383,0.0001263358,0.0005942295,0.00009527909,0.007629592],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99758434,0.00041284252,0.0003201809,0.00021268605,0.0011821889,0.00028777626],"domain_scores_gemma":[0.9942168,0.0009381978,0.0007191347,0.00008576325,0.002691741,0.001348285],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0035012017,0.0003612436,0.00073472585,0.0010437394,0.0029743058,0.0027550862,0.0020068886,0.0021980917,0.0036609943],"category_scores_gemma":[0.0065576853,0.00021747411,0.0006893352,0.001570644,0.002492327,0.001762863,0.0011831102,0.0048430744,0.0010173809],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.00010213155,0.00013547868,0.008400022,0.0028365585,0.0000592486,0.0017757476,0.0011908631,0.00080172764,0.0009657252,0.008288181,0.14269708,0.83274716],"study_design_scores_gemma":[0.00004803803,0.0002336163,0.016035663,0.005747125,0.00012902453,0.0077482117,0.003868197,0.0006128933,0.00043771236,0.007812494,0.95723563,0.00009152001],"about_ca_topic_score_codex":0.16341524,"about_ca_topic_score_gemma":0.34104118,"teacher_disagreement_score":0.16341524,"about_ca_system_score_codex":0.013008546,"about_ca_system_score_gemma":0.021383058,"threshold_uncertainty_score":0.32492816},"labels":[],"label_agreement":null},{"id":"W4415935301","doi":"10.58931/cot.2025.2340","title":"Treatment of dMMR Metastatic Colorectal Cancer in 2025","year":2025,"lang":"","type":"article","venue":"Canadian oncology today.","topic":"Genetic factors in colorectal cancer","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"BC Cancer Agency","funders":"","keywords":"Colorectal cancer; Microsatellite instability; DNA mismatch repair; Immune system; Immune checkpoint; Cancer","score_opus":0.026955920441577165,"score_gpt":0.3520353368922473,"score_spread":0.3250794164506701,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415935301","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.83243185,0.08797593,0.00244049,0.0051597944,0.00067664956,0.0003304095,0.0010941721,0.00021515909,0.06967546],"genre_scores_gemma":[0.974906,0.011872923,0.001150734,0.001018506,0.00017473823,0.000050005558,0.001021943,0.000012470941,0.009792659],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.99996305,0.00000890129,0.000002677839,0.0000043576933,0.0000090650365,0.000011973895],"domain_scores_gemma":[0.9999628,0.000004038833,0.0000058162627,0.000001638404,0.000005587421,0.00002004072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00007393933,0.00013581858,0.00018233513,0.00018905163,0.0001884101,0.00015445982,0.0001275424,0.0002035723,0.0026281695],"category_scores_gemma":[0.00015618031,0.0000394383,0.00022217791,0.00020472698,0.00008442244,0.00007807745,0.000115156625,0.00025534435,0.0005093623],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.0094841,0.00097327365,0.037457973,0.0015319112,0.0003081757,0.010349877,0.00021918798,0.0016411172,0.06298822,0.0021645697,0.041795757,0.8310859],"study_design_scores_gemma":[0.0025840898,0.018337352,0.45047796,0.0007030979,0.00043268217,0.031287156,0.00031588078,0.004072338,0.02224453,0.0014423248,0.46804634,0.000056350593],"about_ca_topic_score_codex":0.0066224188,"about_ca_topic_score_gemma":0.026612494,"teacher_disagreement_score":0.0066224188,"about_ca_system_score_codex":0.0006133392,"about_ca_system_score_gemma":0.00044356295,"threshold_uncertainty_score":0.0131677985},"labels":[],"label_agreement":null},{"id":"W4415935375","doi":"10.58931/cot.2025.2341","title":"First-line Treatment Selection for Advanced Unresectable Biliary Tract Cancer","year":2025,"lang":"","type":"article","venue":"Canadian oncology today.","topic":"Cholangiocarcinoma and Gallbladder Cancer Studies","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":true,"route_ca_aff":true,"route_ca_fund":false,"route_ca_venue":false,"route_about_ca":false,"ca_institutions":"Ottawa Hospital; University of Ottawa","funders":"","keywords":"Biliary tract cancer; Biliary tract; Gallbladder cancer; Gallbladder; Cancer; Selection (genetic algorithm)","score_opus":0.030755536011891602,"score_gpt":0.3467443021864418,"score_spread":0.3159887661745502,"validation_status":"score_only:v0-immature-baseline","prediction":{"id":"W4415935375","genre_codex":"empirical","genre_gemma":"review","domain_codex":null,"domain_gemma":null,"model_version":"metacan-v3-hybrid-931329e0061c","genre_candidate":"review","genre_consensus":null,"domain_candidate":null,"domain_consensus":null,"prediction_status":"machine_predicted_unvalidated","genre_scores_codex":[0.59221774,0.29469442,0.0023096006,0.014078803,0.0024001414,0.00093367894,0.006333598,0.000195053,0.086836934],"genre_scores_gemma":[0.9154919,0.056438975,0.0023049472,0.007738338,0.0013135155,0.00040854374,0.005573828,0.00006352314,0.010666484],"study_design_codex":"design_other","study_design_gemma":"not_applicable","domain_scores_codex":[0.9997954,0.000051543782,0.000023112492,0.000028538598,0.000055888224,0.000045549867],"domain_scores_gemma":[0.99937135,0.00010750888,0.00013509968,0.00002376802,0.00012252867,0.00023984072],"candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0003444589,0.00011272824,0.000511997,0.0004893853,0.00048677155,0.00049816084,0.00027555536,0.00030030843,0.008672201],"category_scores_gemma":[0.0015264787,0.000059781734,0.00049611845,0.00065338635,0.00010911874,0.00040807718,0.00016271266,0.00080365536,0.00089970307],"study_design_candidate":"not_applicable","study_design_consensus":null,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_system_candidate":false,"about_ca_system_consensus":false,"study_design_scores_codex":[0.007838077,0.001379414,0.17710465,0.0028047704,0.00048082753,0.0013754311,0.0005120159,0.0005344599,0.0044713817,0.0016651037,0.08266356,0.7191702],"study_design_scores_gemma":[0.001600784,0.00738531,0.65775955,0.003965732,0.001168928,0.007916151,0.0012054382,0.00077242864,0.0045929938,0.0015451268,0.31200132,0.00008629378],"about_ca_topic_score_codex":0.0066151926,"about_ca_topic_score_gemma":0.025899878,"teacher_disagreement_score":0.008672201,"about_ca_system_score_codex":0.0015569614,"about_ca_system_score_gemma":0.0011635924,"threshold_uncertainty_score":0.029011428},"labels":[],"label_agreement":null}]}